1. Home
  2. ARVN vs CODI Comparison

ARVN vs CODI Comparison

Compare ARVN & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • CODI
  • Stock Information
  • Founded
  • ARVN 2015
  • CODI 2005
  • Country
  • ARVN United States
  • CODI United States
  • Employees
  • ARVN N/A
  • CODI N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • CODI Home Furnishings
  • Sector
  • ARVN Health Care
  • CODI Consumer Discretionary
  • Exchange
  • ARVN Nasdaq
  • CODI Nasdaq
  • Market Cap
  • ARVN 1.4B
  • CODI 1.6B
  • IPO Year
  • ARVN 2018
  • CODI 2006
  • Fundamental
  • Price
  • ARVN $18.57
  • CODI $21.37
  • Analyst Decision
  • ARVN Strong Buy
  • CODI Strong Buy
  • Analyst Count
  • ARVN 13
  • CODI 3
  • Target Price
  • ARVN $63.00
  • CODI $29.00
  • AVG Volume (30 Days)
  • ARVN 860.7K
  • CODI 199.0K
  • Earning Date
  • ARVN 02-25-2025
  • CODI 02-26-2025
  • Dividend Yield
  • ARVN N/A
  • CODI 4.69%
  • EPS Growth
  • ARVN N/A
  • CODI 38.85
  • EPS
  • ARVN N/A
  • CODI 0.56
  • Revenue
  • ARVN $161,100,000.00
  • CODI $2,216,497,000.00
  • Revenue This Year
  • ARVN $239.85
  • CODI $12.78
  • Revenue Next Year
  • ARVN N/A
  • CODI $9.73
  • P/E Ratio
  • ARVN N/A
  • CODI $37.86
  • Revenue Growth
  • ARVN 1.07
  • CODI 16.71
  • 52 Week Low
  • ARVN $17.08
  • CODI $19.76
  • 52 Week High
  • ARVN $53.08
  • CODI $25.07
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 43.53
  • CODI 36.07
  • Support Level
  • ARVN $17.35
  • CODI $21.11
  • Resistance Level
  • ARVN $21.00
  • CODI $21.82
  • Average True Range (ATR)
  • ARVN 1.18
  • CODI 0.53
  • MACD
  • ARVN 0.12
  • CODI -0.11
  • Stochastic Oscillator
  • ARVN 38.01
  • CODI 25.56

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: